Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy

Bone anabolic agents promoting bone formation and rebuilding damaged bones would ideally overcome the limitations of anti‐resorptive therapy, the current standard prescription for osteoporosis. However, the currently prescribed parathyroid hormone (PTH)‐based anabolic drugs present limitations and a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hyun‐Yi, Choi, Sehee, Yoon, Ji‐Hye, Lim, Hwan Jung, Lee, Hyuk, Choi, Jiwon, Ro, Eun Ji, Heo, Jung‐Nyoung, Lee, Weontae, No, Kyoung Tai, Choi, Kang‐Yell
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818757/
https://www.ncbi.nlm.nih.gov/pubmed/26941261
http://dx.doi.org/10.15252/emmm.201505714

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4818757/
https://www.ncbi.nlm.nih.gov/pubmed/26941261
http://dx.doi.org/10.15252/emmm.201505714

Ejemplares similares